- Home
- KRKR vs SNGX Comparison
KRKR vs SNGX Comparison
Compare KRKR & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRKR
- SNGX
- Stock Information
- Founded
- KRKR 2010
- SNGX 1987
- Country
- KRKR China
- SNGX United States
- Employees
- KRKR N/A
- SNGX N/A
- Industry
- KRKR Business Services
- SNGX Biotechnology: Pharmaceutical Preparations
- Sector
- KRKR Consumer Discretionary
- SNGX Health Care
- Exchange
- KRKR Nasdaq
- SNGX Nasdaq
- Market Cap
- KRKR 6.6M
- SNGX 7.4M
- IPO Year
- KRKR 2019
- SNGX 1987
- Fundamental
- Price
- KRKR $3.52
- SNGX $2.42
- Analyst Decision
- KRKR
- SNGX
- Analyst Count
- KRKR 0
- SNGX 0
- Target Price
- KRKR N/A
- SNGX N/A
- AVG Volume (30 Days)
- KRKR 19.8K
- SNGX 621.9K
- Earning Date
- KRKR 09-03-2024
- SNGX 03-14-2025
- Dividend Yield
- KRKR N/A
- SNGX N/A
- EPS Growth
- KRKR N/A
- SNGX N/A
- EPS
- KRKR N/A
- SNGX N/A
- Revenue
- KRKR $41,654,350.00
- SNGX $364,183.00
- Revenue This Year
- KRKR $45.99
- SNGX N/A
- Revenue Next Year
- KRKR $31.46
- SNGX $76.64
- P/E Ratio
- KRKR N/A
- SNGX N/A
- Revenue Growth
- KRKR N/A
- SNGX N/A
- 52 Week Low
- KRKR $2.76
- SNGX $1.83
- 52 Week High
- KRKR $12.20
- SNGX $14.88
- Technical
- Relative Strength Index (RSI)
- KRKR 51.29
- SNGX 35.71
- Support Level
- KRKR $3.21
- SNGX $2.03
- Resistance Level
- KRKR $3.60
- SNGX $2.68
- Average True Range (ATR)
- KRKR 0.21
- SNGX 0.33
- MACD
- KRKR 0.04
- SNGX -0.06
- Stochastic Oscillator
- KRKR 66.86
- SNGX 20.00
About KRKR 36Kr Holdings Inc.
36KR Holdings Inc is a holding company and conducts its business mainly through its subsidiaries, a VIE, and subsidiaries of the VIE. The Group is engaging in providing content and business services to new economy participants in the PRC. Its content production process includes content creation, content editing, screening and monitoring, and content distribution. The Group mainly generates revenues from providing online advertising services, enterprise value-added services, and subscription services. The Group's principal operations and geographic markets are substantially located in PRC.
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).